Delivery Order SPE2DB25D3201-SPE2DB25FNWTK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mekinist 2 mg tablets (30-count units) valued at $9,670.51 with a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 25, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,670.51 on September 9, 2025, for the supply of Mekinist 2 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to be completed by September 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Mekinist 2 mg tablets (30-count units) with a ceiling value of $9,670.51. This is a firm fixed price delivery order with an ultimate completion date of October 10, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mekinist 0.5 mg tablets in quantities of 30s, with a contract ceiling value of $5,701.68 and an ultimate completion date of October 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $19,341.02 on July 22, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $9,670.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This contract represents a non-set-aside, competitively awarded delivery order executed by the prime contractor's Corporate Office, located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,341.02 to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on September 24, 2025, with an ultimate completion date of October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $16,588.64 to AmerisourceBergen Drug Corp for supply of Mekinist 2 mg tablets (30-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy used in melanoma and other oncological treatments, reflecting the...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Mekinist 2 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $37,133.84. This non-set-aside delivery order is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's corporate office in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy medication, indicating this...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mekinist (trametinib) 2 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract has a ceiling value of $19,341.02 and firm fixed pricing, with ultimate completion scheduled for September 2, 2025. The contract is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNWTKDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,670.51 on September 22, 2025, for Mekinist 2 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical supply agreement running through December 2026 that enables the company to furnish a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of DLA contracts demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains, from specialty medications to vaccines and medical devices. This delivery order for Mekinist—a cancer treatment medication—represents a routine replenishment within the company's broader commitment to supplying essential pharmaceutical commodities to Department of Defense healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 9/22/25 |